SCHEMBL25939183

SCHEMBL25939183

C=Cc1ccc(NC)cc1C(=C)C

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.34
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23432350 0.77 EGFR (0.40) EGFRAPP
SCHEMBL27421633 0.76 ALDH1A1 (0.34)
SCHEMBL28559337 0.76 SORT1 (0.32)
SCHEMBL25940821 0.74 CASP1 (0.33)
SCHEMBL11132613 0.73 EGFR (0.38) EGFRAPP
SCHEMBL25938941 0.71 APP (0.37) EGFRAPP
SCHEMBL38659324 0.70 HDAC1 (0.37)
SCHEMBL23428954 0.70 EGFR (0.36) EGFRAPP
SCHEMBL14294037 0.70 SNCA (0.31) APP
SCHEMBL21020940 0.69 EGFR (0.34) EGFRAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820574-B1 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2023-08-09 EP disclosed